Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for application in clinical diagnostics, was notified on 18 November 2016 of the following transactions in its ordinary shares of 5 pence each (“Ordinary Shares”)
(more…)

Notice is hereby given that the Annual General Meeting of Bioventix Plc (the “Company”) will be held at The Winchester Suite, Farnham Castle, Farnham, Surrey, GU9 0AG on Wednesday 7 December 2016 commencing at 2.00pm for the purpose of considering and, if thought fit, passing the following resolutions of which resolutions 1 to 4 (inclusive) will be proposed as ordinary resolutions and resolutions 5 and 6 will be proposed as special resolutions.
(more…)